Eva Muñoz Couselo (Eva Muñoz-Couselo, Eva Munoz-Couselo)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Lymph Node Metastasis

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Laia Clavero-Rovira, Álvaro Gómez-Tomás, Patricia Bassas-Freixas, Domingo Bodet, Berta Ferrer, Javier Hernández-Losa, Eva Muñoz Couselo, Assumpció Pérez-Benavente, Vicente García-Patos, Carla Ferrándiz-Pulido
Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study. Cancers 16 (1) (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Joseph Usset, Axel Rosendahl Huber, Maria A Andrianova, Eduard Batlle, Joan Carles, Edwin Cuppen, Elena Elez, Enriqueta Felip, Marina Gómez-Rey, Deborah Lo Giacco, Francisco Martinez-Jimenez, Eva Muñoz Couselo, Lillian L Siu, Josep Tabernero, Ana Vivancos, Ferran Muinos, Nuria Lopez-Bigas, Núria López-Bigas
Five latent factors underlie response to immunotherapy. Nature genetics (2024)
Laia Clavero-Rovira, Álvaro Gómez-Tomás, Patricia Bassas-Freixas, Domingo Bodet, Berta Ferrer, Javier Hernández-Losa, Eva Muñoz Couselo, Assumpció Pérez-Benavente, Vicente García-Patos, Carla Ferrándiz-Pulido
Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study. Cancers 16 (1) (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Sarah A Weiss, Mario Sznol, Montaser Shaheen, Miguel-Angel Berciano-Guerrero, Eva Muñoz Couselo, Delvys Rodriguez Abreu, Valentina Boni, Lynn M Schuchter, Maria Gonzales Cao, Ana M Arance, Wei Wei, Apar Kishor Ganti, Ralph J Hauke, Alfonso Berrocal, Nicholas O Iannotti, Frank J Hsu, Harriet M Kluger
A Phase II Trial of the CD40 Agonist Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Disease Progression on Anti-PD-1. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Adi Diab, Helen J Gogas, Shahneen Sandhu, Georgina V Long, Paolo Antonio Ascierto, James M G Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, Fernanda Bronzon Damian, Michael Schenker, Aldo Perfetti, Celeste Lebbè, Gaëlle Quéreux, Friedegund Meier, Brendan D Curti, Carlos Rojas, Yull Arriaga, Haisu Yang, Ming Zhou, Shruthi Ravimohan, Paul Statkevich, Mary A Tagliaferri, Nikhil I Khushalani
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Maria Lozano-Rabella, Andrea García-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J Gartner, Michael Ghosh, Francesc Canals, August Vidal Bel, Josep Maria Piulats, Xavier M Guiu, Irene Brana, Eva Muñoz Couselo, Elena Garralda, Andreas Schlosser, Alena Gros
Exploring the immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Åse Bratland, Eva Muñoz Couselo, Laurent Mortier, Osama Roshdy, Rene González, Jacob Schachter, Ana M Arance, Florent Grange, Nicolas Meyer, Abhishek Jagdish Joshi, Salem Billan, Brett G M Hughes, Jean-Jacques Grob, Karthik Ramakrishnan, Joy Ge, Burak Gumuscu, Ramona F Swaby, Ralf Gutzmer
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629. Dermatology and therapy (2023)
Filippo de Braud, Christophe Dooms, Rebecca S Heist, Celeste Lebbè, Martin Wermke, Anas Gazzah, Dirk Schadendorf, Piotr Lukasz Rutkowski, Juergen Wolf, Paolo Antonio Ascierto, Ignacio Gil-Bazo, Shumei Kato, Maria Wolodarski, Meredith A McKean, Eva Muñoz Couselo, Martin Sebastian, Armando Santoro, Vesselina Cooke, Luca Manganelli, Kitty Wan, Anil Gaur, Jaeyeon Kim, Giordano Caponigro, Xuân-Mai Couillebault, Helen Evans, Catarina D Campbell, Sumit Basu, Michele Moschetta, Adil I Daud
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, James M G Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen J Gogas, Stéphane Dalle, Nicolas Meyer, Paolo Antonio Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C Hassel, Caroline Robert, Matteo S Carlino, Anna Maria Di Giacomo, Marcus O Butler, Eva Muñoz Couselo, Michael P Brown, Piotr Lukasz Rutkowski, Andrew M Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz Merino, Andre van der Westhuizen, Alexander M Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J Tenney, Hao Tang, Georgina V Long
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ester Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl, Jürgen Wichmann, Alexandra Arias, Isabel Cuartas, Jasmin Emmenegger, Andrea Romagnani, Luca Mangano, Thomas Lorber, Marco Berrera, Christina Godfried Sie, Fabian Köchl, Jan Eckmann, Romi Feddersen, Martin Kornacker, Gabriel Schnetzler, Marta Cicuéndez, Esteban Cordero, Thomaz E Topczewski, Abel Ferres-Pijoan, Josep González, Francisco Martínez-Ricarte, Eva Muñoz Couselo, Josep Tabernero, James R Bischoff, Piergiorgio Pettazzoni, Joan Seoane
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis. Cancer research 82 (14) (2022)
Marta Ligero, Alonso Garcia-Ruiz, Cristina Viaplana, Guillermo Villacampa, Maria Vittoria Raciti, Jaid Landa, Ignacio Matos, Juan Martin-Liberal, Maria Ochoa de Olza, Cinta Hierro, Joaquin Mateo, Macarena Gonzalez, Rafael Morales-Barrera, Cristina Suarez, Jordi Rodon, Elena Elez, Irene Braña, Eva Muñoz Couselo, Ana Oaknin, Roberta Fasani, Paolo Nuciforo, Debora Gil, Carlota Rubio-Perez, Joan Seoane, Enriqueta Felip Font, Manuel Escobar, Josep Tabernero, Joan Carles, Rodrigo Dienstmann, Elena Garralda, Raquel Perez-Lopez
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors. Radiology 299 (1) (2021)
Azad Saei, Marta Palafox, Touati Benoukraf, Nishi Kumari, Patrick William Jaynes, Prasanna Vasudevan Iyengar, Eva Muñoz Couselo, Paolo G Nuciforo, Javier Cortés, Christopher Nötzel, Nesaretnam Barr Kumarakulasinghe, John Lalith Charles Richard, Zul Fazreen Bin Adam Isa, Brendan Pang, Marta Guzman, Zhou Siqin, Henry Yang, Wai Leong Tam, Violeta Serra, Pieter Johan Adam Eichhorn
Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. The Journal of experimental medicine 215 (7) (2018)